Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia.

Overexpression of plasma apolipoprotein CIII (apo CIII) causes hypertriglyceridemia in transgenic mice. A genetically variant form of the human apo CIII promoter, containing five single base pair changes, has been shown to be associated with severe hypertriglyceridemia in a patient population. In an...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Clin Invest
Principais autores:	Li, W W, Dammerman, M M, Smith, J D, Metzger, S, Breslow, J L, Leff, T
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Clinical Investigation 1995
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185964/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8675624/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI118324
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!